Condition: Diabetic Foot · DFU · Diabetic Foot Ulcer · Sponsor: BioLab Holdings
The purpose of this study is to evaluate the efficacy of human placental membrane products and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
This description comes directly from the study's public registry record.
Bennett Sarver · 888-960-1343 · bsarver@serenagroups.com
Thomas Serena · 814-688-4000 · tserena@serenagroups.com
Always discuss trial participation with your own doctor first.
| Center for Foot and Ankle Disorders | Philidelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07089602